- Home
- COLL vs DJCO Comparison
COLL vs DJCO Comparison
Compare COLL & DJCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- DJCO
- Stock Information
- Founded
- COLL 2002
- DJCO 1987
- Country
- COLL United States
- DJCO United States
- Employees
- COLL N/A
- DJCO N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- DJCO Newspapers/Magazines
- Sector
- COLL Health Care
- DJCO Consumer Discretionary
- Exchange
- COLL Nasdaq
- DJCO Nasdaq
- Market Cap
- COLL 910.2M
- DJCO 793.7M
- IPO Year
- COLL 2015
- DJCO N/A
- Fundamental
- Price
- COLL $30.00
- DJCO $395.74
- Analyst Decision
- COLL Strong Buy
- DJCO
- Analyst Count
- COLL 5
- DJCO 0
- Target Price
- COLL $43.60
- DJCO N/A
- AVG Volume (30 Days)
- COLL 444.8K
- DJCO 14.7K
- Earning Date
- COLL 05-08-2025
- DJCO 05-13-2025
- Dividend Yield
- COLL N/A
- DJCO N/A
- EPS Growth
- COLL 43.56
- DJCO 370.42
- EPS
- COLL 1.86
- DJCO 55.48
- Revenue
- COLL $631,449,000.00
- DJCO $71,642,000.00
- Revenue This Year
- COLL $20.00
- DJCO N/A
- Revenue Next Year
- COLL $3.93
- DJCO N/A
- P/E Ratio
- COLL $16.09
- DJCO $7.06
- Revenue Growth
- COLL 11.41
- DJCO 0.34
- 52 Week Low
- COLL $27.28
- DJCO $333.29
- 52 Week High
- COLL $42.29
- DJCO $602.00
- Technical
- Relative Strength Index (RSI)
- COLL 51.96
- DJCO 46.96
- Support Level
- COLL $29.01
- DJCO $385.52
- Resistance Level
- COLL $30.53
- DJCO $410.99
- Average True Range (ATR)
- COLL 0.89
- DJCO 9.08
- MACD
- COLL 0.04
- DJCO 1.81
- Stochastic Oscillator
- COLL 62.91
- DJCO 38.31
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About DJCO Daily Journal Corp. (S.C.)
Daily Journal Corp publishes newspapers and websites covering California and Arizona and produces several specialized information services. The company operates in two segments: Traditional business and Journal Technologies. It also serves as a newspaper representative specializing in public notice advertising. The majority of revenue is generated from the Journal Technologies segment.